首页> 中文期刊> 《系统医学》 >老年慢性肺源性心脏病合并冠心病患者的临床特点和疗效分析

老年慢性肺源性心脏病合并冠心病患者的临床特点和疗效分析

         

摘要

Objective To study the clinical characteristics, treatment and efficacy of Chronic Cor Pulmonale (CCP) and Coronary Heart Disease(CHD). Methods The data of 66 patients with CCP and CHD who were hospitalized in our hos-pital between January, 2012 and January, 2016 were collected, and they were randomly divided into the research group (33 cases) and control group (33 cases). The control group underwent the conventional treatment. Based on the conven-tional treatment, the research group underwent comprehensive treatment. A comprehensive comparison was made of the clinical efficacy and index of the two groups. Results Total effective rate of the research group was 96.97%, which was obviously higher than that of the control group(78.79%) (P〈0.05). For the research group, the patients' symptom remis-sion time was(1.29±1.02)days, arteriosclerosis hardening index was (3.12±1.06)AI, hospitalization period was(15.52± 3.51)days, which were respectively smaller than that for the control group, and the difference was statistically signifi-cant(P〈0.05). Conclusion The comprehensive method is more effective in treating elderly patients with CCP and CHD, It is worthy of wide application.%目的:探讨老年慢性肺源性心脏病(CCP)合并冠心病(CHD)患者的临床特点、治疗方法与疗效。方法收集2012年1月一2016年1月66例我所诊治老年慢性肺源性心脏病伴发冠心病患者的临床资料,随机分为研究组与对照组各33例。对照组患者实施常规治疗,研究组在常规治疗基础上实施综合治疗。综合对比分析两组患者的临床疗效和临床指标。结果研究组的总有效率达96.97%,显著高于对照组的总有效率78.79%(P〈0.05);研究组患者的临床症状缓解时间为(1.29±1.02)d、动脉硬化指数为(3.12±1.06)AI、住院天数为(15.52±3.51)d,均显著低于对照组,两组比较差异有统计学意义(P〈0.05)。结论对老年慢性肺源性心脏病(CCP)合并冠心病(CHD)患者实施综合治疗具有良好的临床效果,值得临床推广应用。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号